Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87M
-
Number of holders
-
147
-
Total 13F shares, excl. options
-
65.7M
-
Shares change
-
-977K
-
Total reported value, excl. options
-
$1.23B
-
Value change
-
-$23.4M
-
Put/Call ratio
-
0.41
-
Number of buys
-
57
-
Number of sells
-
-78
-
Price
-
$18.73
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q3 2021
185 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.7M shares
of 87M outstanding shares and own 75.55% of the company stock.
Largest 10 shareholders include FMR LLC (6.22M shares), BlackRock Inc. (5M shares), Avoro Capital Advisors LLC (4M shares), EcoR1 Capital, LLC (3.72M shares), VANGUARD GROUP INC (3.26M shares), STATE STREET CORP (3.21M shares), Invesco Ltd. (3M shares), Holocene Advisors, LP (2.71M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.46M shares), and AMERIPRISE FINANCIAL INC (2.39M shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.